High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma (Q40124884)

17 September 2017

title

High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma (English)

1 reference

17 September 2017

Yuanfeng Yang

1

1 reference

17 September 2017

Changwen Zhai

2

1 reference

17 September 2017

Yuan Chang

3

1 reference

17 September 2017

Lin Zhou

4

1 reference

17 September 2017

Tianming Shi

5

1 reference

17 September 2017

Cheng Tan

6

1 reference

17 September 2017

Le Xu

7

1 reference

17 September 2017

Jiejie Xu

8

1 reference

17 September 2017

publication date

31 December 2015

1 reference

17 September 2017

1 reference

17 September 2017

volume

34

1 reference

17 September 2017

issue

5

1 reference

17 September 2017

page(s)

238.e19-26

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

17 September 2017

1 reference

Systematic review of oncological outcomes following surgical management of localised renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Improved prognostication of renal cell carcinoma using an integrated staging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Macrophage diversity enhances tumor progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Protective and pathogenic functions of macrophage subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

CCL2 and interleukin-6 promote survival of human CD11b peripheral blood mononuclear cells and induce M2-type macrophage polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

The immune contexture in human tumours: impact on clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Tumor-associated macrophages: from mechanisms to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Macrophage regulation of tumor responses to anticancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.026

10.1016/J.UROLONC.2015.11.026

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference